Interaction of the Immune and Digestive Systems in the Context of Skin Disease - 0.5 CME Credits
Day One: Friday, October 27, 2023 | 1:30 PM - 2:00 PM PDT:
The complex interplay between the immune response, the gut, and chronic diseases has long fascinated (and perplexed) healthcare providers and scientists. Several immune-related skin diseases have an association with the microbiome and gut-related conditions or symptoms. This association includes psoriatic disease, hidradenitis suppurativa, and atopic dermatitis, which will be discussed in this presentation along with some of the key principles that may explain the link between these conditions, the gut, and aberrant immune response underlying those chronic inflammatory processes.
Learning Objectives:
1. Participants will identify the influence of the microbiome and immune system on the skin and digestive tract.
2. Participants will recall the associations between the gut and chronic immune-mediated skin diseases such as psoriatic disease, hidradenitis suppurativa, and atopic dermatitis.
3. Participants will review the evidence and potential impact that biologics and other therapies may have on the regulation or worsening of gut inflammation.Speaker
Learning Objectives:
1. Participants will identify the influence of the microbiome and immune system on the skin and digestive tract.
2. Participants will recall the associations between the gut and chronic immune-mediated skin diseases such as psoriatic disease, hidradenitis suppurativa, and atopic dermatitis.
3. Participants will review the evidence and potential impact that biologics and other therapies may have on the regulation or worsening of gut inflammation.Speaker
Integrative Cases for Inflammatory Skin Disease Panel - 1.0 CME Credits
Day One: Friday, October 27, 2023 | 3:30 PM - 4:30 PM PDT:
In this session, a panel of experts will discuss cases in which integrative approaches are utilized to manage common skin diseases such as psoriasis and atopic dermatitis.
Learning Objectives:
1. Participants will be able to demonstrate a clinical approach to including integrative interventions in the management of patients with psoriasis and atopic dermatitis.
2. Participants will be able to design a strategy to incorporate integrative practitioners into their practice network.
This activity is supported by an educational grant from UCB and Novartis.
Panelists
Learning Objectives:
1. Participants will be able to demonstrate a clinical approach to including integrative interventions in the management of patients with psoriasis and atopic dermatitis.
2. Participants will be able to design a strategy to incorporate integrative practitioners into their practice network.
This activity is supported by an educational grant from UCB and Novartis.
Panelists
If You Don’t Know Jak, You Will Now: Overview And Update In Psoriasis
Day One: Friday, September 30, 2022 | 1:00 PM - 1:30 PM MT:
Provide an overview of the normal function of the JAK-STAT signaling pathway within cells. We will also discuss the research and clinical efforts that led to the development of small molecules that inhibit this intracellular pathway, known as JAK inhibitors, and their potential therapeutic role for chronic inflammatory conditions such as psoriasis and atopic dermatitis. Finally, we will compare and contrast this novel class of medications to current FDA-approved therapies in psoriasis (e.g., efficacy, onset of action, overall safety, and common adverse events).Speaker
Psoriasis Panel
Day One: Friday, September 30, 2022 | 1:30 PM - 2:30 PM
Psoriasis is a complex disease and management is not a linear process. To understand how different aspects of disease management come together into a harmonious and coherent treatment regimen, an interdisciplinary panel will discuss the various aspects of disease management. Using a case-based discussion, the panel will review the various aspects of treatment.Speaker
